Guillemette Emma Benoist (Guillemette E Benoist)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 4

Top Topics

Prostate Cancer

Smoking Cessation

Top Venues

British journal of clinical pharmacology

Cancer chemotherapy and pharmacology

Biomedical chromatography : BMC

This page only lists publications with an associated author ORCID identifier.

Publications

Guillemette Emma Benoist, Inge M van Oort, David M Burger, Niven Mehra, Nielka P van Erp
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients. Cancer chemotherapy and pharmacology 85 (4) (2020)
Guillemette Emma Benoist, Maarten J van der Doelen, Rob Ter Heine, Nielka P van Erp, Niven Mehra
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer. British journal of clinical pharmacology 84 (5) (2018)
Guillemette Emma Benoist, Eric van der Meulen, Floor J E Lubberman, Winald R Gerritsen, Tineke J Smilde, Jack A Schalken, Jan H Beumer, David M Burger, Nielka P van Erp
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma. Biomedical chromatography : BMC 31 (11) (2017)
Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk, Adrian Javad, Diederik M Somford, David Marinus Burger, Niven Mehra, Nielka P van Erp
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap. British journal of clinical pharmacology 84 (1) (2017)